aluates Reports

$ 0.0

Automative

Global Mammalian Biopharmaceutical Service Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-31Q14878

Global Mammalian Biopharmaceutical Service Market Insights Forecast to 2029

BUY CHAPTERS

Global Mammalian Biopharmaceutical Service Market Research Report 2025

Code: QYRE-Auto-31Q14878

Report

June 2025

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

KBI Biopharma

3P Biopharmaceuticals

Sartorius Stedim Biotech

Merck Millipore

Rentschler Biopharma SE

Northway Biotech

Cambrex

Samsung Biologics

FUJIFILM Diosynth Biotechnologies

GBI

Novartis

Lonza

AGC

AGC Biologics

Abzena

Thermo Fisher Scientific

Catalent

Wuxi Biologics

Boehringer Ingelheim BioXcellence

Mammalian Biopharmaceutical Service Market Size

The global market for Mammalian Biopharmaceutical Service was valued at US$ 18450 million in the year 2024 and is projected to reach a revised size of US$ 30650 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Mammalian Biopharmaceutical Service Market

Mammalian Biopharmaceutical Service refers to the specialized set of processes and support provided by biotechnology and pharmaceutical companies to develop, manufacture, and deliver therapeutic products produced using mammalian cell systems. These services typically involve the use of engineered mammalian cells—such as Chinese hamster ovary (CHO) cells, human embryonic kidney (HEK) cells, or NS0 myeloma cells—to express complex biologics like monoclonal antibodies, recombinant proteins, hormones, vaccines, and gene therapies that cannot be effectively produced in microbial or plant systems. Mammalian biopharmaceutical services cover a broad range of activities, including cell line development, upstream and downstream process optimization, large-scale bioreactor production, purification, analytical testing, regulatory support, and fill-finish operations. These services are critical because mammalian cells provide the necessary post-translational modifications (such as glycosylation) required for the biological activity, stability, and safety of many biopharmaceutical products. By leveraging advanced technologies, strict quality controls, and compliance with Good Manufacturing Practices (GMP), mammalian biopharmaceutical service providers help bring life-saving biologic drugs from research to commercial production, serving therapeutic areas like oncology, immunology, rare diseases, and infectious diseases.

The mammalian biopharmaceutical services sector is experiencing significant growth, driven by the increasing demand for complex biologics such as monoclonal antibodies, recombinant proteins, and cell and gene therapies. Mammalian cell systems, particularly Chinese hamster ovary (CHO) cells, are preferred for producing these therapeutics due to their ability to perform essential post-translational modifications, ensuring the efficacy and safety of the final products. Contract Development and Manufacturing Organizations (CDMOs) are expanding their capabilities to meet this demand.

Process development has become a focal point within the industry, accounting for the largest revenue share in 2024. This emphasis reflects the industry's commitment to optimizing production efficiency and ensuring regulatory compliance. Additionally, analytical and quality control (QC) studies are anticipated to experience the fastest growth, driven by stringent quality assurance requirements and regulatory standards .

Technological advancements are reshaping the manufacturing landscape. The adoption of single-use bioreactors and continuous bioprocessing techniques is enhancing operational efficiency and reducing production costs . Moreover, the integration of digital twins and machine learning algorithms is revolutionizing process development and monitoring, enabling real-time optimization and predictive maintenance .

The biosimilars market is emerging as a significant growth area, offering cost-effective alternatives to existing biologics. This segment is expected to be the fastest-growing from 2025 to 2030, as healthcare systems seek more affordable treatment options . CDMOs are well-positioned to capitalize on this trend by providing scalable and cost-effective manufacturing solutions.

Geographically, North America currently dominates the biopharmaceutical contract manufacturing market, but the Asia-Pacific region is projected to experience higher growth rates in the coming years. This shift is attributed to increased investments in biotechnology infrastructure and favorable regulatory environments in countries like China and India .

In summary, the mammalian biopharmaceutical services industry is poised for continued expansion, driven by technological innovations, the growing demand for complex biologics, and the rise of biosimilars. CDMOs that invest in advanced manufacturing technologies, robust quality control systems, and strategic geographic expansion will be well-positioned to meet the evolving needs of the biopharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Mammalian Biopharmaceutical Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mammalian Biopharmaceutical Service.

The Mammalian Biopharmaceutical Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mammalian Biopharmaceutical Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mammalian Biopharmaceutical Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Mammalian Biopharmaceutical Service Market Report

Report Metric	Details
Report Name	Mammalian Biopharmaceutical Service Market
Accounted market size in year	US$ 18450 million
Forecasted market size in 2031	US$ 30650 million
CAGR	7.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Cell Line Development Analytical Testing Technology Transfer Formulation Development Others
Segment by Application	Pharmaceutical Contract Research Organizations (CROs) Academic and Research Institutes Biotechnology Companies Government Agencies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, Abzena, AGC Biologics, Novartis, KBI Biopharma, 3P Biopharmaceuticals, Sartorius Stedim Biotech, Merck Millipore, Rentschler Biopharma SE, Northway Biotech, Cambrex, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, GBI, Thermo Fisher Scientific, Catalent, WuXi Biologics, Boehringer Ingelheim BioXcellence
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mammalian Biopharmaceutical Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Mammalian Biopharmaceutical Service Market growing?

Ans: The Mammalian Biopharmaceutical Service Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the Mammalian Biopharmaceutical Service Market size in 2031?

Ans: The Mammalian Biopharmaceutical Service Market size in 2031 will be US$ 30650 million.

Who are the main players in the Mammalian Biopharmaceutical Service Market report?

Ans: The main players in the Mammalian Biopharmaceutical Service Market are Lonza, Abzena, AGC Biologics, Novartis, KBI Biopharma, 3P Biopharmaceuticals, Sartorius Stedim Biotech, Merck Millipore, Rentschler Biopharma SE, Northway Biotech, Cambrex, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, GBI, Thermo Fisher Scientific, Catalent, WuXi Biologics, Boehringer Ingelheim BioXcellence

What are the Application segmentation covered in the Mammalian Biopharmaceutical Service Market report?

Ans: The Applications covered in the Mammalian Biopharmaceutical Service Market report are Pharmaceutical, Contract Research Organizations (CROs), Academic and Research Institutes, Biotechnology Companies, Government Agencies

What are the Type segmentation covered in the Mammalian Biopharmaceutical Service Market report?

Ans: The Types covered in the Mammalian Biopharmaceutical Service Market report are Cell Line Development, Analytical Testing, Technology Transfer, Formulation Development, Others

Recommended Reports

Biopharmaceutical Services

Mammalian Expression

Animal Biopharma

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mammalian Biopharmaceutical Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cell Line Development

1.2.3 Analytical Testing

1.2.4 Technology Transfer

1.2.5 Formulation Development

1.2.6 Others

1.3 Market by Application

1.3.1 Global Mammalian Biopharmaceutical Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical

1.3.3 Contract Research Organizations (CROs)

1.3.4 Academic and Research Institutes

1.3.5 Biotechnology Companies

1.3.6 Government Agencies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mammalian Biopharmaceutical Service Market Perspective (2020-2031)

2.2 Global Mammalian Biopharmaceutical Service Growth Trends by Region

2.2.1 Global Mammalian Biopharmaceutical Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Mammalian Biopharmaceutical Service Historic Market Size by Region (2020-2025)

2.2.3 Mammalian Biopharmaceutical Service Forecasted Market Size by Region (2026-2031)

2.3 Mammalian Biopharmaceutical Service Market Dynamics

2.3.1 Mammalian Biopharmaceutical Service Industry Trends

2.3.2 Mammalian Biopharmaceutical Service Market Drivers

2.3.3 Mammalian Biopharmaceutical Service Market Challenges

2.3.4 Mammalian Biopharmaceutical Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Mammalian Biopharmaceutical Service Players by Revenue

3.1.1 Global Top Mammalian Biopharmaceutical Service Players by Revenue (2020-2025)

3.1.2 Global Mammalian Biopharmaceutical Service Revenue Market Share by Players (2020-2025)

3.2 Global Top Mammalian Biopharmaceutical Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Mammalian Biopharmaceutical Service Revenue

3.4 Global Mammalian Biopharmaceutical Service Market Concentration Ratio

3.4.1 Global Mammalian Biopharmaceutical Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mammalian Biopharmaceutical Service Revenue in 2024

3.5 Global Key Players of Mammalian Biopharmaceutical Service Head office and Area Served

3.6 Global Key Players of Mammalian Biopharmaceutical Service, Product and Application

3.7 Global Key Players of Mammalian Biopharmaceutical Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Mammalian Biopharmaceutical Service Breakdown Data by Type

4.1 Global Mammalian Biopharmaceutical Service Historic Market Size by Type (2020-2025)

4.2 Global Mammalian Biopharmaceutical Service Forecasted Market Size by Type (2026-2031)

5 Mammalian Biopharmaceutical Service Breakdown Data by Application

5.1 Global Mammalian Biopharmaceutical Service Historic Market Size by Application (2020-2025)

5.2 Global Mammalian Biopharmaceutical Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Mammalian Biopharmaceutical Service Market Size (2020-2031)

6.2 North America Mammalian Biopharmaceutical Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Mammalian Biopharmaceutical Service Market Size by Country (2020-2025)

6.4 North America Mammalian Biopharmaceutical Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Mammalian Biopharmaceutical Service Market Size (2020-2031)

7.2 Europe Mammalian Biopharmaceutical Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Mammalian Biopharmaceutical Service Market Size by Country (2020-2025)

7.4 Europe Mammalian Biopharmaceutical Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Mammalian Biopharmaceutical Service Market Size (2020-2031)

8.2 Asia-Pacific Mammalian Biopharmaceutical Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Mammalian Biopharmaceutical Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Mammalian Biopharmaceutical Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Mammalian Biopharmaceutical Service Market Size (2020-2031)

9.2 Latin America Mammalian Biopharmaceutical Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Mammalian Biopharmaceutical Service Market Size by Country (2020-2025)

9.4 Latin America Mammalian Biopharmaceutical Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Mammalian Biopharmaceutical Service Market Size (2020-2031)

10.2 Middle East & Africa Mammalian Biopharmaceutical Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza

11.1.1 Lonza Company Details

11.1.2 Lonza Business Overview

11.1.3 Lonza Mammalian Biopharmaceutical Service Introduction

11.1.4 Lonza Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.1.5 Lonza Recent Development

11.2 Abzena

11.2.1 Abzena Company Details

11.2.2 Abzena Business Overview

11.2.3 Abzena Mammalian Biopharmaceutical Service Introduction

11.2.4 Abzena Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.2.5 Abzena Recent Development

11.3 AGC Biologics

11.3.1 AGC Biologics Company Details

11.3.2 AGC Biologics Business Overview

11.3.3 AGC Biologics Mammalian Biopharmaceutical Service Introduction

11.3.4 AGC Biologics Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.3.5 AGC Biologics Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Mammalian Biopharmaceutical Service Introduction

11.4.4 Novartis Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 KBI Biopharma

11.5.1 KBI Biopharma Company Details

11.5.2 KBI Biopharma Business Overview

11.5.3 KBI Biopharma Mammalian Biopharmaceutical Service Introduction

11.5.4 KBI Biopharma Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.5.5 KBI Biopharma Recent Development

11.6 3P Biopharmaceuticals

11.6.1 3P Biopharmaceuticals Company Details

11.6.2 3P Biopharmaceuticals Business Overview

11.6.3 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Introduction

11.6.4 3P Biopharmaceuticals Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.6.5 3P Biopharmaceuticals Recent Development

11.7 Sartorius Stedim Biotech

11.7.1 Sartorius Stedim Biotech Company Details

11.7.2 Sartorius Stedim Biotech Business Overview

11.7.3 Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Introduction

11.7.4 Sartorius Stedim Biotech Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.7.5 Sartorius Stedim Biotech Recent Development

11.8 Merck Millipore

11.8.1 Merck Millipore Company Details

11.8.2 Merck Millipore Business Overview

11.8.3 Merck Millipore Mammalian Biopharmaceutical Service Introduction

11.8.4 Merck Millipore Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.8.5 Merck Millipore Recent Development

11.9 Rentschler Biopharma SE

11.9.1 Rentschler Biopharma SE Company Details

11.9.2 Rentschler Biopharma SE Business Overview

11.9.3 Rentschler Biopharma SE Mammalian Biopharmaceutical Service Introduction

11.9.4 Rentschler Biopharma SE Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.9.5 Rentschler Biopharma SE Recent Development

11.10 Northway Biotech

11.10.1 Northway Biotech Company Details

11.10.2 Northway Biotech Business Overview

11.10.3 Northway Biotech Mammalian Biopharmaceutical Service Introduction

11.10.4 Northway Biotech Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.10.5 Northway Biotech Recent Development

11.11 Cambrex

11.11.1 Cambrex Company Details

11.11.2 Cambrex Business Overview

11.11.3 Cambrex Mammalian Biopharmaceutical Service Introduction

11.11.4 Cambrex Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.11.5 Cambrex Recent Development

11.12 Samsung Biologics

11.12.1 Samsung Biologics Company Details

11.12.2 Samsung Biologics Business Overview

11.12.3 Samsung Biologics Mammalian Biopharmaceutical Service Introduction

11.12.4 Samsung Biologics Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.12.5 Samsung Biologics Recent Development

11.13 FUJIFILM Diosynth Biotechnologies

11.13.1 FUJIFILM Diosynth Biotechnologies Company Details

11.13.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.13.3 FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Introduction

11.13.4 FUJIFILM Diosynth Biotechnologies Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.13.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.14 GBI

11.14.1 GBI Company Details

11.14.2 GBI Business Overview

11.14.3 GBI Mammalian Biopharmaceutical Service Introduction

11.14.4 GBI Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.14.5 GBI Recent Development

11.15 Thermo Fisher Scientific

11.15.1 Thermo Fisher Scientific Company Details

11.15.2 Thermo Fisher Scientific Business Overview

11.15.3 Thermo Fisher Scientific Mammalian Biopharmaceutical Service Introduction

11.15.4 Thermo Fisher Scientific Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.15.5 Thermo Fisher Scientific Recent Development

11.16 Catalent

11.16.1 Catalent Company Details

11.16.2 Catalent Business Overview

11.16.3 Catalent Mammalian Biopharmaceutical Service Introduction

11.16.4 Catalent Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.16.5 Catalent Recent Development

11.17 WuXi Biologics

11.17.1 WuXi Biologics Company Details

11.17.2 WuXi Biologics Business Overview

11.17.3 WuXi Biologics Mammalian Biopharmaceutical Service Introduction

11.17.4 WuXi Biologics Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.17.5 WuXi Biologics Recent Development

11.18 Boehringer Ingelheim BioXcellence

11.18.1 Boehringer Ingelheim BioXcellence Company Details

11.18.2 Boehringer Ingelheim BioXcellence Business Overview

11.18.3 Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Introduction

11.18.4 Boehringer Ingelheim BioXcellence Revenue in Mammalian Biopharmaceutical Service Business (2020-2025)

11.18.5 Boehringer Ingelheim BioXcellence Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

KBI Biopharma

3P Biopharmaceuticals

Sartorius Stedim Biotech

Merck Millipore

Rentschler Biopharma SE

Northway Biotech

Cambrex

Samsung Biologics

FUJIFILM Diosynth Biotechnologies

GBI

Novartis

Lonza

AGC

AGC Biologics

Abzena

Thermo Fisher Scientific

Catalent

Wuxi Biologics

Boehringer Ingelheim BioXcellence

List of Tables

Table 1. Global Mammalian Biopharmaceutical Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cell Line Development

Table 3. Key Players of Analytical Testing

Table 4. Key Players of Technology Transfer

Table 5. Key Players of Formulation Development

Table 6. Key Players of Others

Table 7. Global Mammalian Biopharmaceutical Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Mammalian Biopharmaceutical Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Mammalian Biopharmaceutical Service Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Mammalian Biopharmaceutical Service Market Share by Region (2020-2025)

Table 11. Global Mammalian Biopharmaceutical Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Mammalian Biopharmaceutical Service Market Share by Region (2026-2031)

Table 13. Mammalian Biopharmaceutical Service Market Trends

Table 14. Mammalian Biopharmaceutical Service Market Drivers

Table 15. Mammalian Biopharmaceutical Service Market Challenges

Table 16. Mammalian Biopharmaceutical Service Market Restraints

Table 17. Global Mammalian Biopharmaceutical Service Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Mammalian Biopharmaceutical Service Market Share by Players (2020-2025)

Table 19. Global Top Mammalian Biopharmaceutical Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian Biopharmaceutical Service as of 2024)

Table 20. Ranking of Global Top Mammalian Biopharmaceutical Service Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Mammalian Biopharmaceutical Service Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Mammalian Biopharmaceutical Service, Headquarters and Area Served

Table 23. Global Key Players of Mammalian Biopharmaceutical Service, Product and Application

Table 24. Global Key Players of Mammalian Biopharmaceutical Service, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Mammalian Biopharmaceutical Service Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Mammalian Biopharmaceutical Service Revenue Market Share by Type (2020-2025)

Table 28. Global Mammalian Biopharmaceutical Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Mammalian Biopharmaceutical Service Revenue Market Share by Type (2026-2031)

Table 30. Global Mammalian Biopharmaceutical Service Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Mammalian Biopharmaceutical Service Revenue Market Share by Application (2020-2025)

Table 32. Global Mammalian Biopharmaceutical Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Mammalian Biopharmaceutical Service Revenue Market Share by Application (2026-2031)

Table 34. North America Mammalian Biopharmaceutical Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Mammalian Biopharmaceutical Service Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Mammalian Biopharmaceutical Service Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Mammalian Biopharmaceutical Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Mammalian Biopharmaceutical Service Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Mammalian Biopharmaceutical Service Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Mammalian Biopharmaceutical Service Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Mammalian Biopharmaceutical Service Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Mammalian Biopharmaceutical Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Mammalian Biopharmaceutical Service Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Mammalian Biopharmaceutical Service Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Mammalian Biopharmaceutical Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2026-2031) & (US$ Million)

Table 49. Lonza Company Details

Table 50. Lonza Business Overview

Table 51. Lonza Mammalian Biopharmaceutical Service Product

Table 52. Lonza Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 53. Lonza Recent Development

Table 54. Abzena Company Details

Table 55. Abzena Business Overview

Table 56. Abzena Mammalian Biopharmaceutical Service Product

Table 57. Abzena Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 58. Abzena Recent Development

Table 59. AGC Biologics Company Details

Table 60. AGC Biologics Business Overview

Table 61. AGC Biologics Mammalian Biopharmaceutical Service Product

Table 62. AGC Biologics Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 63. AGC Biologics Recent Development

Table 64. Novartis Company Details

Table 65. Novartis Business Overview

Table 66. Novartis Mammalian Biopharmaceutical Service Product

Table 67. Novartis Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 68. Novartis Recent Development

Table 69. KBI Biopharma Company Details

Table 70. KBI Biopharma Business Overview

Table 71. KBI Biopharma Mammalian Biopharmaceutical Service Product

Table 72. KBI Biopharma Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 73. KBI Biopharma Recent Development

Table 74. 3P Biopharmaceuticals Company Details

Table 75. 3P Biopharmaceuticals Business Overview

Table 76. 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Product

Table 77. 3P Biopharmaceuticals Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 78. 3P Biopharmaceuticals Recent Development

Table 79. Sartorius Stedim Biotech Company Details

Table 80. Sartorius Stedim Biotech Business Overview

Table 81. Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Product

Table 82. Sartorius Stedim Biotech Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 83. Sartorius Stedim Biotech Recent Development

Table 84. Merck Millipore Company Details

Table 85. Merck Millipore Business Overview

Table 86. Merck Millipore Mammalian Biopharmaceutical Service Product

Table 87. Merck Millipore Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 88. Merck Millipore Recent Development

Table 89. Rentschler Biopharma SE Company Details

Table 90. Rentschler Biopharma SE Business Overview

Table 91. Rentschler Biopharma SE Mammalian Biopharmaceutical Service Product

Table 92. Rentschler Biopharma SE Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 93. Rentschler Biopharma SE Recent Development

Table 94. Northway Biotech Company Details

Table 95. Northway Biotech Business Overview

Table 96. Northway Biotech Mammalian Biopharmaceutical Service Product

Table 97. Northway Biotech Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 98. Northway Biotech Recent Development

Table 99. Cambrex Company Details

Table 100. Cambrex Business Overview

Table 101. Cambrex Mammalian Biopharmaceutical Service Product

Table 102. Cambrex Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 103. Cambrex Recent Development

Table 104. Samsung Biologics Company Details

Table 105. Samsung Biologics Business Overview

Table 106. Samsung Biologics Mammalian Biopharmaceutical Service Product

Table 107. Samsung Biologics Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 108. Samsung Biologics Recent Development

Table 109. FUJIFILM Diosynth Biotechnologies Company Details

Table 110. FUJIFILM Diosynth Biotechnologies Business Overview

Table 111. FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Product

Table 112. FUJIFILM Diosynth Biotechnologies Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 113. FUJIFILM Diosynth Biotechnologies Recent Development

Table 114. GBI Company Details

Table 115. GBI Business Overview

Table 116. GBI Mammalian Biopharmaceutical Service Product

Table 117. GBI Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 118. GBI Recent Development

Table 119. Thermo Fisher Scientific Company Details

Table 120. Thermo Fisher Scientific Business Overview

Table 121. Thermo Fisher Scientific Mammalian Biopharmaceutical Service Product

Table 122. Thermo Fisher Scientific Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 123. Thermo Fisher Scientific Recent Development

Table 124. Catalent Company Details

Table 125. Catalent Business Overview

Table 126. Catalent Mammalian Biopharmaceutical Service Product

Table 127. Catalent Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 128. Catalent Recent Development

Table 129. WuXi Biologics Company Details

Table 130. WuXi Biologics Business Overview

Table 131. WuXi Biologics Mammalian Biopharmaceutical Service Product

Table 132. WuXi Biologics Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 133. WuXi Biologics Recent Development

Table 134. Boehringer Ingelheim BioXcellence Company Details

Table 135. Boehringer Ingelheim BioXcellence Business Overview

Table 136. Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Product

Table 137. Boehringer Ingelheim BioXcellence Revenue in Mammalian Biopharmaceutical Service Business (2020-2025) & (US$ Million)

Table 138. Boehringer Ingelheim BioXcellence Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. Authors List of This Report

List of Figures

Figure 1. Mammalian Biopharmaceutical Service Picture

Figure 2. Global Mammalian Biopharmaceutical Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Mammalian Biopharmaceutical Service Market Share by Type: 2024 VS 2031

Figure 4. Cell Line Development Features

Figure 5. Analytical Testing Features

Figure 6. Technology Transfer Features

Figure 7. Formulation Development Features

Figure 8. Others Features

Figure 9. Global Mammalian Biopharmaceutical Service Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Mammalian Biopharmaceutical Service Market Share by Application: 2024 VS 2031

Figure 11. Pharmaceutical Case Studies

Figure 12. Contract Research Organizations (CROs) Case Studies

Figure 13. Academic and Research Institutes Case Studies

Figure 14. Biotechnology Companies Case Studies

Figure 15. Government Agencies Case Studies

Figure 16. Mammalian Biopharmaceutical Service Report Years Considered

Figure 17. Global Mammalian Biopharmaceutical Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Mammalian Biopharmaceutical Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Mammalian Biopharmaceutical Service Market Share by Region: 2024 VS 2031

Figure 20. Global Mammalian Biopharmaceutical Service Market Share by Players in 2024

Figure 21. Global Mammalian Biopharmaceutical Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Mammalian Biopharmaceutical Service Revenue in 2024

Figure 23. North America Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Mammalian Biopharmaceutical Service Market Share by Country (2020-2031)

Figure 25. United States Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Mammalian Biopharmaceutical Service Market Share by Country (2020-2031)

Figure 29. Germany Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Mammalian Biopharmaceutical Service Market Share by Region (2020-2031)

Figure 37. China Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Mammalian Biopharmaceutical Service Market Share by Country (2020-2031)

Figure 45. Mexico Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Country (2020-2031)

Figure 49. Turkey Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Mammalian Biopharmaceutical Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Lonza Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 53. Abzena Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 54. AGC Biologics Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 56. KBI Biopharma Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 57. 3P Biopharmaceuticals Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 58. Sartorius Stedim Biotech Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 59. Merck Millipore Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 60. Rentschler Biopharma SE Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 61. Northway Biotech Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 62. Cambrex Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 63. Samsung Biologics Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 64. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 65. GBI Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 67. Catalent Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 68. WuXi Biologics Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 69. Boehringer Ingelheim BioXcellence Revenue Growth Rate in Mammalian Biopharmaceutical Service Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Biopharmaceutical Analytical Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Antibody Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mammalian Protein Expression Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical and Vaccines Market Research Report 2024

Global BioPharma Service Market Research Report 2024

Biopharmaceutical Development Support Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Humanization Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biotechnology Pharmaceutical Services Outsourcing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biobank Service Market Research Report 2025

Biopharmaceuticals Contract Manufacturing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Single Use Equipment for Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Lab Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical Stock Solution Market Research Report 2024

Antibody Sequencing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bioconjugates Service Market Research Report 2024

Drug Discovery and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical Drug Delivery Technologies Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions